Kirsten B on Clubhouse

Bio

RN, BSN, M.Sc., Drug Safety Scientist at MedAssessment


Stage 4 Colon Cancer Survivor. Lynch Syndrome MLH1+.
 
8+ years of clinical research (academia and industry) including drug safety case processing and regulatory reporting.
8 years of RN experience in urgent care, ER, medical/surgical, and renal.
M.Sc. in Immunology from Rush University.
 
MedAssessment is a physican-led boutique CRO of drug safety experts focused on pharmacovigilance in drug development.  Early stage drug safety requires highly specialized expertise, such as the ability to separate true signals from noise in an atmosphere of small sample sizes, and forms the basis for the drug safety profile through the life of the drug.  MedAssessment specializes in collaborating with pharmaceutical companies working in early development across a multitude of indications including but not limited to oncology, liver disease, and rare diseases.  www.MedAssessment.com

Linked In: kirsten-brady-bab5801b